My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes.

    Bretzel RG, Arnolds S, Medding J, Linn T.

    Diabetes Care. 2004 May;27(5):1023-7.PMID: 15111514 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    3.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    4.

    Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.

    Christiansen JS, Vaz JA, Metelko Z, Bogoev M, Dedov I.

    Diabetes Obes Metab. 2003 Nov;5(6):446-54.PMID: 14617231 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.

    Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.

    Acta Diabetol. 2000 Mar;37(1):41-6.PMID: 10928235 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

    Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

    Clin Ther. 2005;27 Suppl B:S57-74. Review.PMID: 16519038 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

    Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

    Clin Ther. 2007 Nov;29(11):2374-84.PMID: 18158078 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

    Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.

    Diabetologia. 2004 Apr;47(4):622-9.PMID: 15298338 [PubMed - indexed for MEDLINE]Related articles

    9.

    Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.

    Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L.

    Diabetes Care. 2000 May;23(5):583-8.PMID: 10834413 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

    Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

    Clin Ther. 2008 Nov;30(11):1976-87.PMID: 19108786 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Intensified insulin therapy of type 2 diabetes mellitus: pre- or postprandial injection of aspart insulin?]

    Jungmann E.

    Dtsch Med Wochenschr. 2005 May 20;130(20):1254-7. German. PMID: 15889321 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

    Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

    13.

    Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

    Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

    Diabetes Care. 2001 Apr;24(4):631-6.PMID: 11315821 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus.

    Chlup R, Zapletalová J, Seckar P, Malá E, Doubravová B, Táncosová S, Chlupová L, Pukowietz L, Zatloukal P.

    Diabetes Technol Ther. 2007 Jun;9(3):223-31.PMID: 17561792 [PubMed - indexed for MEDLINE]Related articles

    15.

    Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

    Bastyr EJ 3rd, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE.

    Diabetes Care. 2000 Sep;23(9):1236-41.PMID: 10977012 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50.

    Gao Y, Li G, Li Y, Guo X, Yuan G, Gong Q, Yan L, Zheng Y, Zhang J.

    Int J Clin Pract. 2008 Sep;62(9):1344-51. Epub 2008 Jul 24.PMID: 18657196 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

    Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group.

    Diabet Med. 2000 Nov;17(11):762-70.PMID: 11131100 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

    Chow CC, Tsang LW, Sorensen JP, Cockram CS.

    Diabetes Care. 1995 Mar;18(3):307-14.PMID: 7555472 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

    Home PD, Lindholm A, Hylleberg B, Round P.

    Diabetes Care. 1998 Nov;21(11):1904-9.PMID: 9802741 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.

    Raz I, Mouritzen U, Vaz J, Hershkovitz T, Wainstein J, Harman-Boehm I.

    Clin Ther. 2003 Dec;25(12):3109-23.PMID: 14749149 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity